The first ethanol sclerotherapy of an accessory cavitated uterine mass

Abstract

This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

Accessory cavitated uterine malformation: Enhancing awareness about this unexplored perpetrator of dysmenorrhea

“…Scarring of the uterus and the accompanying danger of rupture are complications that ethanol sclerotherapy can help women to avoid. 72 Moreover, it does all this without any dangers associated with major surgery. Nonetheless, there is a tiny but substantial chance of leakage when sclerosant chemicals are in the peritoneum.…”

“…Merviel et al 72 first utilized ethanol sclerotherapy in a diagnosed case of ACUM. Four patients in the Naftalin et al 14 study reported significant improvements in their pain levels after sclerotherapy.…”

“…Damage to the cavity lining caused by sclerosant substances (ethanol, ethanolamine oleate, hypertonic such as saline, glucose, etc.) leads to inflammatory changes and, eventually, fibrosis of the endometrial lining, which completely seals off the accessory cavity.Merviel et al72 first utilized ethanol sclerotherapy in a diagnosed case of ACUM. Four patients in the Naftalin et al14 study reported significant improvements in their pain levels after sclerotherapy.Sadly, secondary problems returned in half of the patients, requiring additional surgical intervention.…”

Accessory cavitated uterine malformation (ACUM): A hidden face of dysmenorrhea

“…Merviel et al first described the use of ethanol sclerotherapy in a case diagnosed with ACUM. 70 In the study by Naftalin et al, four patients chose to have sclerotherapy and had sufficient pain relief on follow-up. 53 But later, half of them had a recurrence of secondary symptoms and underwent surgical management.…”

“…Ethanol sclerotherapy can avoid uterine scarring and the secondary risk of uterine rupture. 70 Moreover, it avoids all the risks of major surgery. However, there is the risk of inadvertent leakage of sclerosant agents installed in the peritoneum.…”